Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director departure
Appointed director
|
|
IVERIC bio, Inc. (OPHT)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/11/2023 |
8-K
| Resignation/termination of a director |
| 07/06/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/23/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/01/2023 |
8-K
| Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other E...|
Docs:
|
"Agreement and Plan of Merger, by and among Astellas US Holding, Inc., Berry Merger Sub, Inc., IVERIC bio, Inc. and, solely as provided by Section ‎8.10(b) therein, Astellas Pharma Inc",
"Amendment to IVERIC bio, Inc.’s Amended and Restated Bylaws",
"Investor Contact:" |
|
| 03/20/2023 |
8-K
| Quarterly results |
| 03/10/2023 |
8-K
| Other Events Interactive Data |
| 03/01/2023 |
8-K
| Quarterly results |
| 01/06/2023 |
8-K
| Results of Operations and Financial Condition, Departure of Directors or Certain Officers; Election of Directors; Appointment... |
| 12/27/2022 |
8-K
| Entry into a Material Definitive Agreement Interactive Data |
| 12/12/2022 |
8-K
| Quarterly results |
| 12/05/2022 |
8-K
| Quarterly results |
| 11/28/2022 |
8-K
| Quarterly results |
| 11/17/2022 |
8-K
| Quarterly results |
| 11/03/2022 |
8-K
| Quarterly results |
| 09/28/2022 |
8-K
| Investor presentation |
| 09/07/2022 |
8-K
| Other Events Interactive Data |
| 09/06/2022 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 07/26/2022 |
8-K
| Entry into a Material Definitive Agreement, Results of Operations and Financial Condition, Creation of a Direct Financial Obl... |
| 07/05/2022 |
8-K
| Quarterly results |
| 05/18/2022 |
8-K
| Quarterly results |
| 05/04/2022 |
8-K
| Quarterly results |
| 04/04/2022 |
8-K
| Other Events Interactive Data |
| 03/25/2022 |
8-K
| Other Events Interactive Data |
| 02/24/2022 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 01/11/2022 |
8-K
| Appointed a new director |
| 01/11/2022 |
8-K
| Other Events Interactive Data |
| 11/09/2021 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 10/25/2021 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"9,000,000 Shares IVERIC BIO, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT",
"Letter re: IVERIC bio, Inc. - Registration Statement on Form S-3",
"Iveric Bio Announces Pricing of Upsized Public Offering of Common Stock , October 21, 2021 – IVERIC bio, Inc. , today announced the pricing of an upsized underwritten public offering of 9,000,000 shares of its common stock at a price to the public of $16.75 per share, less underwriting discounts and commissions. In addition, in connection with the offering, the Company has granted the underwriters an option for a period of 30 days to purchase up to an additional 1,350,000 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares are being offered by the Company. The gross proceeds from the offering are expected to be approximately $150.8 million, before underwriting discounts and commissions and offering expenses payable by the Comp..." |
|
| 10/21/2021 |
8-K
| Other Events Interactive Data |
| 10/01/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/04/2021 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 07/14/2021 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits Interactive Data|
Docs:
|
"11,650,000 Shares IVERIC BIO, INC. COMMON STOCK, $0.001 PAR VALUE PER SHARE UNDERWRITING AGREEMENT",
"Letter re: IVERIC bio., Inc. - Registration Statement on Form S-3",
"IVERIC bio, Inc. Announces Pricing of $100 Million Public Offering of Common Stock , July 12, 2021 – IVERIC bio, Inc. , today announced the pricing of an underwritten public offering of 11,650,000 shares of its common stock at a price to the public of $8.60 per share, less underwriting discounts and commissions. In addition, in connection with the offering, the Company has granted the underwriters an option for a period of 30 days to purchase up to an additional 1,747,500 shares of common stock at the public offering price, less underwriting discounts and commissions. All of the shares are being offered by the Company. The gross proceeds from the offering are expected to be approximately $100.2 million, before underwriting discounts and commissions and offering expenses payable by the Comp..." |
|
| 07/12/2021 |
8-K
| Other Events Interactive Data |
| 07/06/2021 |
8-K
| Quarterly results |
|
|
|